| Citation: |
ZHANG Ning, LIU Xiaohong, KANG Lin, CHEN Wei, QU Xuan, ZHU Minglei, SUN Xiaohong. Impact of Sarcopenia on Long-term Outcomes in Elderly Inpatients with Type 2 Diabetes Mellitus: A Prospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1348-1355. DOI: 10.12290/xhyxzz.2024-0287
|
To investigate the collective influence of sarcopenia on the extended prognosis of hospitalized elderly individuals with type 2 diabetes mellitus(T2DM).
Patients with T2DM aged 65 years and older, who were admitted to the Geriatrics Department of Peking Union Medical College Hospital between January 2017 and January 2021, were consecutively enrolled in the study. The presence of sarcopenia was evaluated based on the diagnostic criteria established by the Asian Working Group for Sarcopenia(AWGS) in 2014. Additionally, assessments were made on the patients' comorbidities, functional status, nutritional status, and geriatric syndromes. Follow-up was conducted through outpatient visits and telephone calls to monitor outcomes such as severe disability, rehospitalization, and all-cause mortality. Cox regression analysis was performed to investigate the impact of concurrent sarcopenia on the long-term prognosis of hospitalized elderly individuals with T2DM.
A total of 244 elderly inpatients with T2DM who met specific criteria were included in the study, comprising 110 males(45.1%) and 134 females(54.9%), with ages ranging from 65 to 93 years and a median age of 74 years. Sarcopenia was observed in 25.4%(62/244) of patients. Over a follow-up period of three to seven years(median 5.6 years), elderly T2DM patients with sarcopenia exhibited significantly higher rates of severe disability, rehospitalization, and all-cause death compared to those without sarcopenia(all P < 0.001). Cox regression analysis, adjusting for gender, age, and comorbidities, revealed that sarcopenia was a significant predictor of severe disability(HR=4.693, 95% CI: 1.253-17.579, P=0.022), rehospitalization(HR=1.755, 95% CI: 1.053-2.926, P=0.031), and all-cause death(HR=2.255, 95% CI: 1.078-4.713, P=0.031). Additionally, the age-adjusted Charlson comorbidity index emerged as an independent risk factor for all-cause death(HR=1.237, 95% CI: 1.046-1.464, P=0.013).
The prevalence of sarcopenia is notably high among hospitalized elderly patients with T2DM, greatly affecting their long-term prognosis. It is imperative for clinicians to prioritize screening and implement interventions for sarcopenia in elderly T2DM patients to improve their quality of life and overall prognosis.
| [1] |
Cruz-Jentoft A J, Sayer A A. Sarcopenia[J]. Lancet, 2019, 393(10191): 2636-2646. DOI: 10.1016/S0140-6736(19)31138-9
|
| [2] |
姜珊, 康琳, 刘晓红. 2019亚洲肌少症诊断及治疗共识解读[J]. 中华老年医学杂志, 2020, 39(4): 373-376. DOI: 10.3760/cma.j.issn.0254-9026.2020.04.002
Jiang S, Kang L, Liu X H. Interpretation of Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. Chin J Geriatr, 2020, 39(4): 373-376. DOI: 10.3760/cma.j.issn.0254-9026.2020.04.002
|
| [3] |
Qiao Y S, Chai Y H, Gong H J, et al. The association between diabetes mellitus and risk of sarcopenia: accumulated evidences from observational studies[J]. Front Endocrinol(Lausanne), 2021, 12: 782391. DOI: 10.3389/fendo.2021.782391
|
| [4] |
Feng L Y, Gao Q Q, Hu K Y, et al. Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis[J]. J Clin Endocrinol Metab, 2022, 107(5): 1470-1483. DOI: 10.1210/clinem/dgab884
|
| [5] |
Liccini A P, Malmstrom T K. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus[J]. J Am Med Dir Assoc, 2016, 17(9): 846-851. DOI: 10.1016/j.jamda.2016.07.007
|
| [6] |
Sugimoto K, Tabara Y, Ikegami H, et al. Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus[J]. J Diabetes Investig, 2019, 10(6): 1471-1479. DOI: 10.1111/jdi.13070
|
| [7] |
Murata Y, Kadoya Y, Yamada S, et al. Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors[J]. Diabetol Int, 2018, 9(2): 136-142. DOI: 10.1007/s13340-017-0339-6
|
| [8] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华糖尿病杂志, 2014, 6(7): 447-498. DOI: 10.3760/cma.j.issn.1674-5809.2014.07.004
Chinese Diabete Society. Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in China(2013 Edition)[J]. Chin J Diabetes Mellitus, 2014, 6(7): 447-498. DOI: 10.3760/cma.j.issn.1674-5809.2014.07.004
|
| [9] |
Chen L K, Liu L K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia[J]. J Am Med Dir Assoc, 2014, 15(2): 95-101. DOI: 10.1016/j.jamda.2013.11.025
|
| [10] |
Reijneveld S A, Spijker J, Dijkshoorn H. Katz' ADL index assessed functional performance of Turkish, Moroccan, and Dutch elderly[J]. J Clin Epidemiol, 2007, 60(4): 382-388. DOI: 10.1016/j.jclinepi.2006.02.022
|
| [11] |
Isik E I, Yilmaz S, Uysal I, et al. Adaptation of the Lawton instrumental activities of daily living scale to Turkish: validity and reliability study[J]. Ann Geriatr Med Res, 2020, 24(1): 35-40. DOI: 10.4235/agmr.19.0051
|
| [12] |
Wang Z, Zhong Y, Zhou Y D, et al. The prognostic value of the age-adjusted Charlson comorbidity index among the elderly with breast cancer[J]. Clin Interv Aging, 2023, 18: 1163-1174. DOI: 10.2147/CIA.S414727
|
| [13] |
Folven K, Biringer E, Abrahamsen J F. Mini nutritional assessment short-form(MNA-SF) predicts institutionalisation in an intermediate post-acute care setting[J]. J Nutr Health Aging, 2018, 22(2): 199-204. DOI: 10.1007/s12603-017-0879-2
|
| [14] |
Gohil R A, Mockford K A, Mazari F, et al. Balance impairment, physical ability, and its link with disease severity in patients with intermittent claudication[J]. Ann Vasc Surg, 2013, 27(1): 68-74. DOI: 10.1016/j.avsg.2012.05.005
|
| [15] |
Yang M, Hu X Y, Wang H Z, et al. Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study[J]. J Cachexia Sarcopenia Muscle, 2017, 8(2): 251-258. DOI: 10.1002/jcsm.12163
|
| [16] |
Zhang J J, Ju X Z, Feng Z, et al. Progressive resistance exercise training to prevent lower-limb lymphedema after cervical cancer surgery: a feasibility study[J]. Asia Pac J Oncol Nurs, 2022, 9(1): 32-38. DOI: 10.1016/j.apjon.2021.12.002
|
| [17] |
Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging[J]. Curr Opin Clin Nutr Metab Care, 2004, 7(4): 405-410. DOI: 10.1097/01.mco.0000134362.76653.b2
|
| [18] |
Wilkinson D J, Piasecki M, Atherton P J. The age-related loss of skeletal muscle mass and function: measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans[J]. Ageing Res Rev, 2018, 47: 123-132. DOI: 10.1016/j.arr.2018.07.005
|
| [19] |
Zugasti Murillo A, Petrina-Jáuregui M E, Ripa-Ciáurriz C, et al. SeDREno study-prevalence of hospital malnutrition according to GLIM criteria, ten years after the PREDyCES study[J]. Nutr Hosp, 2021, 38(5): 1016-1025.
|
| [20] |
Anagnostis P, Gkekas N K, Achilla C, et al. Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis[J]. Calcif Tissue Int, 2020, 107(5): 453-463. DOI: 10.1007/s00223-020-00742-y
|
| [21] |
De Freitas M M, De Oliveira V L P, Grassi T, et al. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus(EWGSOP) in elderly patients with type 2 diabetes mellitus[J]. Exp Gerontol, 2020, 132: 110835. DOI: 10.1016/j.exger.2020.110835
|
| [22] |
Song E, Hwang S Y, Park M J, et al. Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: a longitudinal nationwide population-based study[J]. Metabolism, 2023, 148: 155678. DOI: 10.1016/j.metabol.2023.155678
|
| [23] |
Memelink R G, Pasman W J, Bongers A, et al. Effect of an enriched protein drink on muscle mass and glycemic control during combined lifestyle intervention in older adults with obesity and type 2 diabetes: a double-blind RCT[J]. Nutrients, 2020, 13(1): 64. DOI: 10.3390/nu13010064
|
| [24] |
Luger M, Holstein B, Schindler K, et al. Feasibility and efficacy of an isocaloric high-protein vs. standard diet on insulin requirement, body weight and metabolic parameters in patients with type 2 diabetes on insulin therapy[J]. Exp Clin Endocrinol Diabetes, 2013, 121(5): 286-294. DOI: 10.1055/s-0033-1341472
|
| [25] |
Gao S Y, Yu L, Yi G Z, et al. Exercise intervention as a therapy in patients with diabetes mellitus and sarcopenia: a meta-analysis[J]. Diabetes Ther, 2022, 13(7): 1311-1325. DOI: 10.1007/s13300-022-01275-3
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: